Trial · NCT00550862
Adverse events185
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 185
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pruritus | Skin and subcutaneous tissue disorders | Obeticholic Acid (OCA) 10 Milligrams (mg) | 18 | 38 | 23 |
| other | Pruritus | Skin and subcutaneous tissue disorders | OCA 25 mg | 41 | 48 | 52 |
| other | Pruritus | Skin and subcutaneous tissue disorders | OCA 50 mg | 33 | 41 | 60 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Placebo | 19 | 38 | 21 |
| other | Pruritus | Skin and subcutaneous tissue disorders | LTSE OCA Total | 68 | 78 | |
| other | Dry Eye | Eye disorders | Obeticholic Acid (OCA) 10 Milligrams (mg) | 0 | 38 | 0 |
| other | Dry Eye | Eye disorders | OCA 25 mg | 3 | 48 | 3 |
| other | Dry Eye | Eye disorders | OCA 50 mg | 2 | 41 | 2 |
| other | Dry Eye | Eye disorders | Placebo | 1 | 38 | 1 |
| other | Dry Eye | Eye disorders | LTSE OCA Total | 0 | 78 | |
| other | Abdominal distension | Gastrointestinal disorders | Obeticholic Acid (OCA) 10 Milligrams (mg) | 2 | 38 | 2 |
| other | Abdominal distension | Gastrointestinal disorders | OCA 25 mg | 0 | 48 | 0 |
| other | Abdominal distension | Gastrointestinal disorders | OCA 50 mg | 4 | 41 | 4 |
| other | Abdominal distension | Gastrointestinal disorders | Placebo | 1 | 38 | 1 |
| other | Abdominal distension | Gastrointestinal disorders | LTSE OCA Total | 6 | 78 | |
| other | Constipation | General disorders | Obeticholic Acid (OCA) 10 Milligrams (mg) | 3 | 38 | 3 |
| other | Constipation | General disorders | OCA 25 mg | 4 | 48 | 4 |
| other | Constipation | General disorders | OCA 50 mg | 3 | 41 | 4 |
| other | Constipation | General disorders | Placebo | 3 | 38 | 3 |
| other | Constipation | General disorders | LTSE OCA Total | 7 | 78 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00550862/events